Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication.
BMJ Case Rep
; 13(6)2020 Jun 14.
Article
in English
| MEDLINE | ID: covidwho-832843
ABSTRACT
A 57-year-old man presented with a progressive flaccid symmetrical motor and sensory neuropathy following a 1-week history of cough and malaise. He was diagnosed with Guillain-Barré syndrome secondary to COVID-19 and started on intravenous immunoglobulin. He proceeded to have worsening respiratory function and needed intubation and mechanical ventilation. This is the first reported case of this rare neurological complication of COVID-19 in the UK, but it adds to a small but growing body of international evidence to suggest a significant association between these two conditions. Increasing appreciation of this by clinicians will ensure earlier diagnosis, monitoring and treatment of patients presenting with this.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Respiration, Artificial
/
Immunoglobulins, Intravenous
/
Coronavirus Infections
/
Guillain-Barre Syndrome
/
Pandemics
/
Betacoronavirus
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
Bcr-2020-236182
Similar
MEDLINE
...
LILACS
LIS